Palatin Technologies (NYSEAMERICAN:PTN – Get Rating) issued its earnings results on Thursday. The biopharmaceutical company reported ($1.34) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.81) by ($0.53), RTT News reports. During the same period last year, the business posted ($1.50) EPS.
Palatin Technologies Trading Down 12.4 %
Palatin Technologies stock opened at $6.95 on Friday. The company has a market cap of $64.41 million, a price-to-earnings ratio of -46.33 and a beta of 0.79. Palatin Technologies has a 52-week low of $4.00 and a 52-week high of $24.00.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on PTN. LADENBURG THALM/SH SH boosted their target price on shares of Palatin Technologies to $50.00 and gave the company a “buy” rating in a research report on Friday, September 9th. HC Wainwright reissued a “buy” rating and set a $70.00 target price on shares of Palatin Technologies in a research note on Thursday, September 8th.
Hedge Funds Weigh In On Palatin Technologies
Palatin Technologies Company Profile
Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder.
- Get a free copy of the StockNews.com research report on Palatin Technologies (PTN)
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Is The Golden Age Of Homebuilding Already Over?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.